← 產業報告目錄

Tomosynthesis Market Research Report by Product (2D/3D Combo, 3D-Only), by Configuration (U-Arm, Others), by Application (Breast Cancer Screening, Diagnostic Imaging), by End-User (Hospitals and Specialty Clinics, Diagnostic Imaging Centers, Research & Academic Institutes), and by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-11-04頁數 203報告編號 MRFRHC39277HCR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

The global tomosynthesis market is projected to reach USD 13,188.32 million by 2035, growing at a CAGR of 11.68% from 2025 to 2035. The global tomosynthesis market revolves around 3D breast imaging systems that are highly advanced and contribute to early cancer detection while reducing the number of false positives compared to conventional mammography. Increasing Prevalence of Breast Cancer The rising global burden of breast cancer plays a major role in driving the tomosynthesis market, more than any other factor. With millions of new cases every year, healthcare systems are turning their attention to early and accurate detection as a priority. The increased demand has a direct and immediate effect on the widespread adoption of digital breast tomosynthesis (DBT). Product & Segment Breakdown Product • 2D/3D Combo: Offers dual imaging for improved accuracy. • 3D-Only: Provides full-depth visualization of breast tissue. Configuration • U-Arm: Ensures flexible positioning for precise scans. • Others: Includes alternative setups for varied workflows. Application • Breast Cancer Screening: Used for routine early detection. • Diagnostic Imaging: Supports detailed assessment of abnormalities. End-User • Hospitals and Specialty Clinics: Deliver advanced imaging services daily. • Diagnostic Imaging Centers: Focus on specialized breast imaging tests. • Research & Academic Institutes: Support innovation and clinical studies. Regional Analysis The escalated worldwide market for tomosynthesis is expanding globally with the help of new cases of breast cancer and the need for precise diagnostic procedures. North America and Europe are status quo with the trend, while the Asia-Pacific is catching up very fast. South America and MEA are slowly but surely progressing, notwithstanding the existing cost barriers. Technology-Driven Competitive Advantage Rising breast cancer cases and rapid technological advancements are accelerating global adoption of tomosynthesis systems. The move towards early and preventive diagnosis is a key factor that is strengthening demand not only in hospitals but in other healthcare settings as well. Key Report Attributes • Market Size 2024: USD 3,888.72 Million • Market Size 2035: USD 13,188.32 Million • CAGR (2025-2035): 11.68% • Base Year: 2025 • Market Forecast Period: 2025-2035 Industry Segmentations Growth • By Product: 2D/3D Combo - 11.08%, 3D-Only - 12.46%. • By Configuration: U-Arm - 12.67%, Others - 10.83%. • By Application: Breast Cancer Screening - 11.47%, Diagnostic Imaging - 14.75%. • By End-User: Hospitals and Specialty Clinics - 11.38%, Diagnostic Imaging Centers - 12.81%.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ........... 22 2 MARKET INTRODUCTION ........ 24 2.1 DEFINITION .......... 24 2.2 SCOPE OF THE STUDY ....... 24 2.3 RESEARCH OBJECTIVE ........... 24 2.4 MARKET STRUCTURE ....... 25 3 RESEARCH METHODOLOGY ....... 26 3.1 OVERVIEW ........... 26 3.2 DATA FLOW ......... 28 3.2.1 DATA MINING PROCESS ......... 28 3.3 PURCHASED DATABASE: ....... 29 3.4 SECONDARY SOURCES: ......... 30 3.4.1 SECONDARY RESEARCH DATA FLOW: ......... 31 3.5 PRIMARY RESEARCH: ....... 32 3.5.1 PRIMARY RESEARCH DATA FLOW: ........ 33 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ........ 34 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ........ 34 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: .......... 35 3.6.1 REVENUE ANALYSIS APPROACH ....... 35 3.7 DATA FORECASTING......... 36 3.7.1 DATA FORECASTING TYPE ........... 36 3.8 DATA MODELING ......... 37 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 37 3.8.2 DATA MODELING: ......... 38 3.9 TEAMS AND ANALYST CONTRIBUTION .......... 40 4 MARKET DYNAMICS ........... 42 4.1 INTRODUCTION ....... 42 4.2 DRIVERS ........... 42 4.2.1 INCREASING PREVALENCE OF BREAST CANCER ......... 42 4.2.2 TECHNOLOGICAL ADVANCEMENTS ....... 43 4.2.3 SHIFT TOWARD EARLY AND PREVENTIVE DIAGNOSIS ........... 43 4.3 RESTRAINTS ......... 44 4.3.1 HIGH EQUIPMENT AND OPERATIONAL COSTS ....... 44 4.3.2 REGULATORY AND APPROVAL CHALLENGES ........ 44 4.4 OPPORTUNITY ......... 45 4.4.1 EXPANSION INTO EMERGING MARKETS ........... 45 4.4.2 GOVERNMENT INITIATIVES AND AWARENESS PROGRAMS ........ 46 5 MARKET FACTOR ANALYSIS ....... 47 5.1 PORTER'S FIVE FORCES MODEL ......... 47 5.1.1 THREAT OF NEW ENTRANTS ........ 47 5.1.2 BARGAINING POWER OF SUPPLIERS ........... 48 5.1.3 THREAT OF SUBSTITUTES ........... 48 5.1.4 BARGAINING POWER OF BUYERS ........... 48 5.1.5 INTENSITY OF RIVALRY .......... 48 5.2 IMPACT OF COVID-19 ON THE GLOBAL TOMOSYNTHESIS MARKET ......... 49 6 GLOBAL TOMOSYNTHESIS MARKET, BY PRODUCT ......... 51 6.1 OVERVIEW ........... 51 6.2 2D/3D COMBO ........... 53 6.3 3D-ONLY .......... 54 7 GLOBAL TOMOSYNTHESIS MARKET, BY CONFIGURATION ....... 55 7.1 OVERVIEW ........... 55 7.2 U-ARM ......... 57 7.3 OTHERS ....... 58 8 GLOBAL TOMOSYNTHESIS MARKET, BY APPLICATION ........ 59 8.1 OVERVIEW ........... 59 8.2 BREAST CANCER SCREENING ........ 61 8.3 DIAGNOSTIC IMAGING ......... 62 9 GLOBAL TOMOSYNTHESIS MARKET, BY END USER ........ 63 9.1 OVERVIEW ........... 63 9.2 HOSPITALS AND SPECIALTY CLINICS ......... 65 9.3 DIAGNOSTIC IMAGING CENTERS....... 66 9.4 RESEARCH & ACADEMIC INSTITUTE .......... 66 10 GLOBAL TOMOSYNTHESIS MARKET, BY REGION ....... 67 10.1 OVERVIEW ........... 67 10.2 NORTH AMERICA ......... 68 10.2.1 US....... 71 10.2.2 CANADA ....... 72 10.3 EUROPE ....... 74 10.3.1 GERMANY .......... 77 10.3.2 FRANCE ........ 78 10.3.3 UK ........... 79 10.3.4 ITALY ....... 81 10.3.5 SPAIN ........... 82 10.3.6 RUSSIA ......... 83 10.3.7 REST OF EUROPE .......... 85 10.4 ASIA PACIFIC ....... 87 10.4.1 CHINA ........... 90 10.4.2 INDIA ....... 91 10.4.3 JAPAN .......... 93 10.4.4 SOUTH KOREA ......... 94 10.4.5 MALAYSIA ......... 95 10.4.6 THAILAND .......... 97 10.4.7 INDONESIA ......... 98 10.4.8 REST OF ASIA PACIFIC....... 99 10.5 SOUTH AMERICA .......... 101 10.5.1 BRAZIL .......... 104 10.5.2 MEXICO ........ 105 10.5.3 ARGENTINA ....... 106 10.5.4 REST OF SOUTH AMERICA ........... 108 10.6 MIDDLE EAST AND AFRICA ....... 110 10.6.1 GCC COUNTRIES........... 113 10.6.2 SOUTH AFRICA ........ 114 10.6.3 REST OF MEA .......... 115 11 COMPETITIVE LANDSCAPE ......... 118 11.1 INTRODUCTION ....... 118 11.2 MARKET SHARE ANALYSIS, 2024 ........ 118 11.3 COMPETITOR DASHBOARD ........... 119 11.4 PUBLIC PLAYERS STOCK SUMMARY ........... 120 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL ......... 120 11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ........... 121 11.1.1 PRODUCT LAUNCH ....... 121 11.1.2 SOFTWARE LAUNCH .......... 122 11.1.3 PREMARKET APPROVAL ......... 122 11.1.4 PRODUCT APPROVAL ........ 122 11.1.5 INSTALLATION ........ 123 11.1.6 PARTNERSHIP ......... 123 11.1.7 ACQUISITION .......... 125 11.1.8 EQUITY ......... 126 11.1.9 INNOVATION ........... 126 12 COMPANY PROFILES ......... 127 12.1 HOLOGIC, INC. ......... 127 12.1.1 COMPANY OVERVIEW ........ 127 12.1.2 FINANCIAL OVERVIEW ....... 128 12.1.3 PRODUCTS OFFERED ......... 129 12.1.4 KEY DEVELOPMENTS ......... 129 12.1.5 SWOT ANALYSIS .......... 130 12.1.6 KEY STRATEGIES .......... 131 12.2 GE HEALTHCARE .......... 132 12.2.1 COMPANY OVERVIEW ........ 132 12.2.2 FINANCIAL OVERVIEW ....... 133 12.2.3 PRODUCTS OFFERED ......... 134 12.2.4 KEY DEVELOPMENTS ......... 135 12.2.5 SWOT ANALYSIS .......... 136 12.2.6 KEY STRATEGIES .......... 136 12.3 FUJIFILM HOLDINGS CORPORATION .......... 137 12.3.1 COMPANY OVERVIEW ........ 137 12.3.2 FINANCIAL OVERVIEW ....... 138 12.3.3 PRODUCT OFFERED ........... 139 12.3.4 KEY DEVELOPMENTS ......... 139 12.3.5 KEY STRATEGIES .......... 140 12.4 TRIVITRON HEALTHCARE PRIVATE LIMITED ......... 141 12.4.1 COMPANY OVERVIEW ........ 141 12.4.2 FINANCIAL OVERVIEW ....... 142 12.4.3 PRODUCTS OFFERED ......... 142 12.4.4 KEY DEVELOPMENTS ......... 142 12.4.5 KEY STRATEGIES .......... 143 12.5 PLANMED OY ....... 144 12.5.1 COMPANY OVERVIEW ........ 144 12.5.2 FINANCIAL OVERVIEW ....... 145 12.5.3 PRODUCTS OFFERED ......... 145 12.5.4 KEY DEVELOPMENTS ......... 146 12.5.5 KEY STRATEGIES .......... 146 12.6 SIEMENS HEALTHINEERS ........... 147 12.6.1 COMPANY OVERVIEW ........ 147 12.6.2 FINANCIAL OVERVIEW ....... 148 12.6.3 PRODUCTS OFFERED ......... 149 12.6.4 KEY DEVELOPMENTS ......... 149 12.6.5 SWOT ANALYSIS .......... 150 12.6.6 KEY STRATEGIES .......... 151 12.7 PERKINELMER .......... 152 12.7.1 COMPANY OVERVIEW ........ 152 12.7.2 FINANCIAL OVERVIEW ....... 153 12.7.3 PRODUCTS OFFERED ......... 153 12.7.4 KEY DEVELOPMENTS ......... 153 12.7.5 SWOT ANALYSIS .......... 154 12.7.6 KEY STRATEGIES .......... 154 12.8 CANON MEDICAL SYSTEMS CORPORATION ....... 155 12.8.1 COMPANY OVERVIEW ........ 155 12.8.2 FINANCIAL OVERVIEW ....... 155 12.8.3 PRODUCTS OFFERED ......... 156 12.8.4 KEY DEVELOPMENTS ......... 156 12.8.5 SWOT ANALYSIS .......... 157 12.8.6 KEY STRATEGIES .......... 158 12.9 ANALOGIC CORPORATION ....... 159 12.9.1 COMPANY OVERVIEW ........ 159 12.9.2 FINANCIAL OVERVIEW ....... 159 12.9.3 PRODUCTS OFFERED ......... 160 12.9.4 KEY DEVELOPMENTS ......... 160 12.9.5 KEY STRATEGIES .......... 160 12.10 SHIMADZU CORPORATION ....... 161 12.10.1 COMPANY OVERVIEW ........ 161 12.10.2 FINANCIAL OVERVIEW ....... 162 12.10.3 PRODUCTS OFFERED ......... 163 12.10.4 KEY DEVELOPMENTS ......... 163 12.10.5 KEY STRATEGIES .......... 163 12.11 NP JSC AMICO ........... 164 12.11.1 COMPANY OVERVIEW ........ 164 12.11.2 FINANCIAL OVERVIEW ....... 164 12.11.3 PRODUCTS OFFERED ......... 164 12.11.4 KEY DEVELOPMENTS ......... 165 12.11.5 SWOT ANALYSIS .......... 165 12.11.6 KEY STRATEGIES .......... 165 12.12 VMI MÉDICA ........ 167 12.12.1 COMPANY OVERVIEW ........ 167 12.12.2 FINANCIAL OVERVIEW ....... 167 12.12.3 PRODUCTS OFFERED ......... 167 12.12.4 KEY DEVELOPMENTS ......... 168 12.12.5 SWOT ANALYSIS .......... 168 12.12.6 KEY STRATEGIES .......... 169 12.13 BEMEMS CO., LTD. ........ 170 12.13.1 COMPANY OVERVIEW ........ 170 12.13.2 FINANCIAL OVERVIEW ....... 170 12.13.3 PRODUCTS OFFERED ......... 171 12.13.4 KEY DEVELOPMENTS ......... 171 12.13.5 KEY STRATEGIES .......... 171 12.14 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD. ........ 172 12.14.1 COMPANY OVERVIEW ........ 172 12.14.2 FINANCIAL OVERVIEW ....... 172 12.14.3 PRODUCTS OFFERED ......... 172 12.14.4 KEY DEVELOPMENTS ......... 173 12.14.5 KEY STRATEGIES .......... 173 12.15 SHENZHEN LANDWIND INDUSTRY CO. .......... 174 12.15.1 COMPANY OVERVIEW ........ 174 12.15.2 FINANCIAL OVERVIEW ....... 174 12.15.3 PRODUCTS OFFERED ......... 174 12.15.4 KEY DEVELOPMENTS ......... 174 12.15.5 KEY STRATEGIES .......... 175 12.16 PAYAMED ELECTRONIC INDUSTRIES CO........ 176 12.16.1 COMPANY OVERVIEW ........ 176 12.16.2 FINANCIAL OVERVIEW ....... 176 12.16.3 PRODUCTS OFFERED ......... 176 12.16.4 KEY DEVELOPMENTS ......... 176 12.16.5 KEY STRATEGIES .......... 177 12.17 MEDICAL TECHNOLOGIES LTD (MTL) ........ 178 12.17.1 COMPANY OVERVIEW ........ 178 12.17.2 FINANCIAL OVERVIEW ....... 178 12.17.3 PRODUCT OFFERED ........... 178 12.17.4 KEY DEVELOPMENTS ......... 179 12.17.5 KEY STRATEGIES .......... 179 12.18 METALTRONICA S.P.A. .......... 180 12.18.1 COMPANY OVERVIEW ........ 180 12.18.2 FINANCIAL OVERVIEW ....... 180 12.18.3 PRODUCT OFFERED ........... 180 12.18.4 KEY DEVELOPMENTS ......... 181 12.18.5 KEY STRATEGIES .......... 181 12.19 LOTUS HEALTHCARE ........ 182 12.19.1 COMPANY OVERVIEW ........ 182 12.19.2 FINANCIAL OVERVIEW ....... 183 12.19.3 PRODUCT OFFERED ........... 183 12.19.4 KEY DEVELOPMENTS ......... 183 12.19.5 KEY STRATEGIES .......... 183 12.20 KONINKLIJKE PHILIPS N.V. ........ 184 12.20.1 COMPANY OVERVIEW ........ 184 12.20.2 FINANCIAL OVERVIEW ....... 185 12.20.3 PRODUCTS OFFERED ......... 186 12.20.4 KEY DEVELOPMENTS ......... 186 12.20.5 SWOT ANALYSIS .......... 187 12.20.6 KEY STRATEGIES .......... 187 12.21 ALLENGERS .......... 188 12.21.1 COMPANY OVERVIEW ........ 188 12.21.2 FINANCIAL OVERVIEW ....... 189 12.21.3 PRODUCTS OFFERED ......... 189 12.21.4 KEY DEVELOPMENTS ......... 189 12.21.5 SWOT ANALYSIS .......... 190 12.21.6 KEY STRATEGIES .......... 190 12.22 IMS GIOTTO S.P.A ......... 191 12.22.1 COMPANY OVERVIEW ........ 191 12.22.2 FINANCIAL OVERVIEW ....... 191 12.22.3 PRODUCTS OFFERED ......... 192 12.22.4 KEY DEVELOPMENTS ......... 192 12.22.5 KEY STRATEGIES .......... 192 12.23 SHENZHEN ANGELL TECHNOLOGY CO., LTD. ......... 193 12.23.1 COMPANY OVERVIEW ........ 193 12.23.2 FINANCIAL OVERVIEW ....... 194 12.23.3 PRODUCT OFFERED ........... 194 12.23.4 KEY DEVELOPMENTS ......... 194 12.23.5 KEY STRATEGIES .......... 194 12.24 KONICA MINOLTA, INC. ........ 195 12.24.1 COMPANY OVERVIEW ........ 195 12.24.2 FINANCIAL OVERVIEW ....... 196 12.24.3 PRODUCTS OFFERED ......... 197 12.24.4 KEY DEVELOPMENTS ......... 197 12.24.5 SWOT ANALYSIS .......... 198 12.24.6 KEY STRATEGIES .......... 199 12.25 ELECTRON CO. ......... 200 12.25.1 COMPANY OVERVIEW ........ 200 12.25.2 FINANCIAL OVERVIEW ....... 200 12.25.3 PRODUCTS OFFERED ......... 201 12.25.4 KEY DEVELOPMENTS ......... 201 12.25.5 KEY STRATEGIES .......... 201 13 DATA CITATIONS ........... 202
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 39 TABLE 2 GLOBAL TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 52 TABLE 3 GLOBAL TOMOSYNTHESIS MARKET, FOR 2D/3D COMBO, BY REGION, 2019–2035 (USD MILLION) 53 TABLE 4 GLOBAL TOMOSYNTHESIS MARKET, FOR 3D-ONLY, BY REGION, 2019–2035 (USD MILLION) 54 TABLE 5 GLOBAL TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 56 TABLE 6 GLOBAL TOMOSYNTHESIS MARKET, FOR U-ARM, BY REGION, 2019–2035 (USD MILLION) 57 TABLE 7 GLOBAL TOMOSYNTHESIS MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION) 58 TABLE 8 GLOBAL TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 60 TABLE 9 GLOBAL TOMOSYNTHESIS MARKET, FOR BREAST CANCER SCREENING, BY REGION, 2019–2035 (USD MILLION) 61 TABLE 10 GLOBAL TOMOSYNTHESIS MARKET, FOR DIAGNOSTIC IMAGING, BY REGION, 2019–2035 (USD MILLION) 62 TABLE 11 GLOBAL TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 64 TABLE 12 GLOBAL TOMOSYNTHESIS MARKET, FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2019–2035 (USD MILLION) 65 TABLE 13 GLOBAL TOMOSYNTHESIS MARKET, FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2019–2035 (USD MILLION) 66 TABLE 14 GLOBAL TOMOSYNTHESIS MARKET, FOR RESEARCH & ACADEMIC INSTITUTE, BY REGION, 2019–2035 (USD MILLION) 66 TABLE 15 GLOBAL TOMOSYNTHESIS MARKET, BY REGION, 2019-2035 (USD MILLION) 67 TABLE 16 NORTH AMERICA TOMOSYNTHESIS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 69 TABLE 17 NORTH AMERICA TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 70 TABLE 18 NORTH AMERICA TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 70 TABLE 19 NORTH AMERICA TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 70 TABLE 20 NORTH AMERICA TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 71 TABLE 21 US TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 71 TABLE 22 US TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 71 TABLE 23 US TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 72 TABLE 24 US TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 72 TABLE 25 CANADA TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 72 TABLE 26 CANADA TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 73 TABLE 27 CANADA TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 73 TABLE 28 CANADA TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 73 TABLE 29 EUROPE TOMOSYNTHESIS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 75 TABLE 30 EUROPE: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 75 TABLE 31 EUROPE: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 76 TABLE 32 EUROPE: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 76 TABLE 33 EUROPE: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 76 TABLE 34 GERMANY: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 77 TABLE 35 GERMANY: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 77 TABLE 36 GERMANY: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 77 TABLE 37 GERMANY: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 78 TABLE 38 FRANCE: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 78 TABLE 39 FRANCE: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 78 TABLE 40 FRANCE: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 79 TABLE 41 FRANCE: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 79 TABLE 42 UK: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 79 TABLE 43 UK: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 80 TABLE 44 UK: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 80 TABLE 45 UK: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 80 TABLE 46 ITALY: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 81 TABLE 47 ITALY: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 81 TABLE 48 ITALY: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 81 TABLE 49 ITALY: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 82 TABLE 50 SPAIN: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 82 TABLE 51 SPAIN: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 82 TABLE 52 SPAIN: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 83 TABLE 53 SPAIN: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 83 TABLE 54 RUSSIA TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 83 TABLE 55 RUSSIA TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 84 TABLE 56 RUSSIA TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 84 TABLE 57 RUSSIA TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 84 TABLE 58 REST OF EUROPE TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 85 TABLE 59 REST OF EUROPE TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 85 TABLE 60 REST OF EUROPE TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 85 TABLE 61 REST OF EUROPE TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 86 TABLE 62 ASIA PACIFIC TOMOSYNTHESIS MARKET, BY REGION, 2019–2035 (USD MILLION) 88 TABLE 63 ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 89 TABLE 64 ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 89 TABLE 65 ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 89 TABLE 66 ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 90 TABLE 67 CHINA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 90 TABLE 68 CHINA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 90 TABLE 69 CHINA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 91 TABLE 70 CHINA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 91 TABLE 71 INDIA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 91 TABLE 72 INDIA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 92 TABLE 73 INDIA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 92 TABLE 74 INDIA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 92 TABLE 75 JAPAN: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 93 TABLE 76 JAPAN: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 93 TABLE 77 JAPAN: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 93 TABLE 78 JAPAN: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 94 TABLE 79 SOUTH KOREA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 94 TABLE 80 SOUTH KOREA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 94 TABLE 81 SOUTH KOREA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 95 TABLE 82 SOUTH KOREA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 95 TABLE 83 MALAYSIA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 95 TABLE 84 MALAYSIA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 96 TABLE 85 MALAYSIA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 96 TABLE 86 MALAYSIA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 96 TABLE 87 THAILAND: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 97 TABLE 88 THAILAND: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 97 TABLE 89 THAILAND: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 97 TABLE 90 THAILAND: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 98 TABLE 91 INDONESIA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 98 TABLE 92 INDONESIA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 98 TABLE 93 INDONESIA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 99 TABLE 94 INDONESIA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 99 TABLE 95 REST OF ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 99 TABLE 96 REST OF ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 100 TABLE 97 REST OF ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 100 TABLE 98 REST OF ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 100 TABLE 99 SOUTH AMERICA TOMOSYNTHESIS MARKET, BY REGION, 2019–2035 (USD MILLION) 102 TABLE 100 SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 102 TABLE 101 SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 103 TABLE 102 SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 103 TABLE 103 SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 103 TABLE 104 BRAZIL: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 104 TABLE 105 BRAZIL: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 104 TABLE 106 BRAZIL: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 104 TABLE 107 BRAZIL: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 105 TABLE 108 MEXICO: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 105 TABLE 109 MEXICO: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 105 TABLE 110 MEXICO: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 106 TABLE 111 MEXICO: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 106 TABLE 112 ARGENTINA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 106 TABLE 113 ARGENTINA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 107 TABLE 114 ARGENTINA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 107 TABLE 115 ARGENTINA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 107 TABLE 116 REST OF SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 108 TABLE 117 REST OF SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 108 TABLE 118 REST OF SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 108 TABLE 119 REST OF SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 109 TABLE 120 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 111 TABLE 121 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 111 TABLE 122 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 112 TABLE 123 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 112 TABLE 124 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 112 TABLE 125 GCC COUNTRIES: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 113 TABLE 126 GCC COUNTRIES: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 113 TABLE 127 GCC COUNTRIES: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 113 TABLE 128 GCC COUNTRIES: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 114 TABLE 129 SOUTH AFRICA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 114 TABLE 130 SOUTH AFRICA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 114 TABLE 131 SOUTH AFRICA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 115 TABLE 132 SOUTH AFRICA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 115 TABLE 133 REST OF MEA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 115 TABLE 134 REST OF MEA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 116 TABLE 135 REST OF MEA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 116 TABLE 136 REST OF MEA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 116 TABLE 137 PRODUCT LAUNCH 121 TABLE 138 SOFTWARE LAUNCH 122 TABLE 139 PREMARKET APPROVAL 122 TABLE 140 PRODUCT APPROVAL 122 TABLE 141 INSTALLATION 123 TABLE 142 PARTNERSHIP 123 TABLE 143 ACQUISITION 125 TABLE 144 EQUITY 126 TABLE 145 INNOVATION 126 TABLE 146 HOLOGIC, INC.: PRODUCTS OFFERED 129 TABLE 147 HOLOGIC, INC.: KEY DEVELOPMENTS 129 TABLE 148 GE HEALTHCARE: PRODUCTS OFFERED 134 TABLE 149 GE HEALTHCARE: KEY DEVELOPMENTS 135 TABLE 150 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 139 TABLE 151 FUJIFILM HOLDINGS CORPORATION: KEY DEVELOPMENTS 139 TABLE 152 TRIVITRON HEALTHCARE PRIVATE LIMITED: PRODUCTS OFFERED 142 TABLE 153 TRIVITRON HEALTHCARE PRIVATE LIMITED: KEY DEVELOPMENTS 142 TABLE 154 PLANMED OY: PRODUCTS OFFERED 145 TABLE 155 PLANMED OY: KEY DEVELOPMENTS 146 TABLE 156 SIEMENS HEALTHINEERS: PRODUCTS OFFERED 149 TABLE 157 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS 149 TABLE 158 PERKINELMER: PRODUCTS OFFERED 153 TABLE 159 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 156 TABLE 160 CANON MEDICAL SYSTEMS CORPORATION: KEY DEVELOPMENTS 156 TABLE 161 ANALOGIC CORPORATION: PRODUCTS OFFERED 160 TABLE 162 SHIMADZU CORPORATION: PRODUCTS OFFERED 163 TABLE 163 SHIMADZU CORPORATION: KEY DEVELOPMENTS 163 TABLE 164 NP JSC AMICO: PRODUCTS OFFERED 164 TABLE 165 VMI MÉDICA: PRODUCTS OFFERED 167 TABLE 166 BEMEMS CO., LTD.: PRODUCTS OFFERED 171 TABLE 167 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 172 TABLE 168 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.: KEY DEVELOPMENTS 173 TABLE 169 SHENZHEN LANDWIND INDUSTRY CO.: PRODUCTS OFFERED 174 TABLE 170 PAYAMED ELECTRONIC INDUSTRIES CO.: PRODUCTS OFFERED 176 TABLE 171 MEDICAL TECHNOLOGIES LTD: PRODUCTS OFFERED 178 TABLE 172 METALTRONICA S.P.A.: PRODUCTS OFFERED 180 TABLE 173 LOTUS HEALTHCARE.: PRODUCTS OFFERED 183 TABLE 174 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED TABLE 175 ALLENGERS: PRODUCTS OFFERED TABLE 176 ALLENGERS : KEY DEVELOPMENTS TABLE 177 IMS GIOTTO S.P.A: PRODUCTS OFFERED TABLE 178 SHENZHEN ANGELL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED TABLE 179 KONICA MINOLTA, INC.: PRODUCTS OFFERED TABLE 180 KONICA MINOLTA, INC.: KEY DEVELOPMENTS TABLE 181 ELECTRON CO.: PRODUCTS OFFERED LIST OF FIGURES FIGURE 1 GLOBAL TOMOSYNTHESIS MARKET: STRUCTURE 25 FIGURE 2 GLOBAL TOMOSYNTHESIS MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035) 42 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2035) 44 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2035) 45 FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL TOMOSYNTHESIS MARKET 47 FIGURE 6 GLOBAL TOMOSYNTHESIS MARKET, BY PRODUCT, 2024 & 2035 (USD MILLION) 52 FIGURE 7 GLOBAL TOMOSYNTHESIS MARKET SHARE (%), BY PRODUCT, 2024 53 FIGURE 8 GLOBAL TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2024 & 2035 (USD MILLION) 56 FIGURE 9 GLOBAL TOMOSYNTHESIS MARKET SHARE (%), BY CONFIGURATION, 2024 57 FIGURE 10 GLOBAL TOMOSYNTHESIS MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 60 FIGURE 11 GLOBAL TOMOSYNTHESIS MARKET SHARE (%), BY APPLICATION, 2024 61 FIGURE 12 GLOBAL TOMOSYNTHESIS MARKET, BY END USER, 2024 & 2035 (USD MILLION) 64 FIGURE 13 GLOBAL TOMOSYNTHESIS MARKET SHARE (%), BY END USER, 2024 65 FIGURE 14 GLOBAL TOMOSYNTHESIS MARKET, BY REGION, 2024 & 2035 (USD MILLION) 67 FIGURE 15 GLOBAL TOMOSYNTHESIS MARKET SHARE (%), BY REGION, 2024 68 FIGURE 16 NORTH AMERICA: TOMOSYNTHESIS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 69 FIGURE 17 NORTH AMERICA: TOMOSYNTHESIS MARKET SHARE (%), BY COUNTRY, 2024 69 FIGURE 18 EUROPE: TOMOSYNTHESIS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 74 FIGURE 19 NORTH AMERICA: TOMOSYNTHESIS MARKET SHARE (%), BY COUNTRY, 2024 75 FIGURE 20 ASIA PACIFIC: TOMOSYNTHESIS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 87 FIGURE 21 ASIA PACIFIC: TOMOSYNTHESIS MARKET SHARE, BY COUNTRY, 2024 (%) 88 FIGURE 22 SOUTH AMERICA: TOMOSYNTHESIS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 101 FIGURE 23 SOUTH AMERICA: TOMOSYNTHESIS MARKET SHARE, BY COUNTRY, 2024 (%) 102 FIGURE 24 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 110 FIGURE 25 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET SHARE, BY COUNTRY, 2024 (%) 111 FIGURE 26 GLOBAL TOMOSYNTHESIS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 118 FIGURE 27 COMPETITOR DASHBOARD: GLOBAL TOMOSYNTHESIS MARKET 119 FIGURE 28 HOLOGIC, INC.: FINANCIAL OVERVIEW SNAPSHOT 128 FIGURE 29 HOLOGIC, INC.: SWOT ANALYSIS 130 FIGURE 30 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 133 FIGURE 31 GE HEALTHCARE: SWOT ANALYSIS 136 FIGURE 32 FUJIFILM HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 138 FIGURE 33 SIEMENS HEALTHINEERS: FINANCIAL OVERVIEW SNAPSHOT 148 FIGURE 34 SIEMENS HEALTHINEERS: SWOT ANALYSIS 150 FIGURE 35 PERKINELMER: FINANCIAL OVERVIEW SNAPSHOT 153 FIGURE 36 PERKINELMER: SWOT ANALYSIS 154 FIGURE 37 CANON MEDICAL SYSTEMS CORPORATION: SWOT ANALYSIS 157 FIGURE 38 SHIMADZU CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 162 FIGURE 39 NP JSC AMICO: SWOT ANALYSIS 165 FIGURE 40 VMI MÉDICA: SWOT ANALYSIS 168 FIGURE 41 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 42 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS FIGURE 43 ALLENGERS : SWOT ANALYSIS FIGURE 44 KONICA MINOLTA, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 45 KONICA MINOLTA, INC.: SWOT ANALYSIS

提及公司

GE HealthcareSiemens HealthineersShimadzu CorporationFUJIFILM Holdings CorporationCanon Medical Systems CorporationHologicInc.Analogic CorporationTrivitron Healthcare Private LimitedPlanmed OYPerkinElmer

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們